Literature DB >> 6318432

Identification and characterization of deoxyribonucleoprotein complexes containing the major DNA-binding protein of herpes simplex virus type 1.

S S Leinbach, J F Casto.   

Abstract

Nuclear extracts were prepared from cells infected with herpes simplex virus type 1 (HSV-1) and fractionated by sucrose gradient centrifugation to identify deoxyribonucleoprotein complexes involved in viral replication. Large amounts of an HSV-1 induced protein with a molecular weight of about 133,000 sedimented as a broad peak in the 25 S region of the gradient and cosedimented with 13 S DNA fragments. The sedimentation of both the protein and DNA decreased upon treatment of nuclear extracts with DNase. This result indicated that the protein and DNA were associated in deoxyribonucleoprotein complexes. The protein was identified as the HSV-encoded major DNA-binding protein ICP8 based on its molecular weight, its association with DNA in nuclear extracts, and its immunoprecipitation with monospecific antiserum and monoclonal antibody to ICP8. Deoxyribonucleoprotein complexes containing ICP8 could be immunoprecipitated from nuclear extracts. When DNA was extracted from these immunoprecipitates, fractionated by agarose gel electrophoresis, transferred to nitrocellulose paper, and hybridized to 32P-labeled HSV-1 or cell DNA, both HSV-1 and cell DNA sequences were identified. Cesium chloride gradient analysis of the immunoprecipitated DNA indicated that duplex DNA was present in the complexes. Thus, the major DNA-binding protein of HSV-1 is associated with both duplex HSV-1 and cell DNA in vivo.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6318432     DOI: 10.1016/0042-6822(83)90496-8

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  14 in total

1.  Genetic evidence for multiple nuclear functions of the herpes simplex virus ICP8 DNA-binding protein.

Authors:  M Gao; D M Knipe
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

2.  Surface lysine and tyrosine residues are required for interaction of the major herpes simplex virus type 1 DNA-binding protein with single-stranded DNA.

Authors:  W T Ruyechan; J W Olson
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

3.  Potential role for herpes simplex virus ICP8 DNA replication protein in stimulation of late gene expression.

Authors:  M Gao; D M Knipe
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

4.  Localization of the herpes simplex virus type 1 65-kilodalton DNA-binding protein and DNA polymerase in the presence and absence of viral DNA synthesis.

Authors:  L D Goodrich; P A Schaffer; D I Dorsky; C S Crumpacker; D S Parris
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

5.  An immunoassay for the study of DNA-binding activities of herpes simplex virus protein ICP8.

Authors:  C K Lee; D M Knipe
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

6.  A genetic test for expression of a functional herpes simplex virus DNA-binding protein from a transfected plasmid.

Authors:  M P Quinlan; D M Knipe
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

7.  Identification and characterization of a major early cytomegalovirus DNA-binding protein.

Authors:  D G Anders; A Irmiere; W Gibson
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

8.  In vitro characterization of a thermolabile herpes simplex virus DNA-binding protein.

Authors:  W T Ruyechan; A Chytil; C M Fisher
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

9.  Mapping of the transcriptional initiation site of the herpes simplex virus type 1 ICP8 gene in infected and transfected cells.

Authors:  L Su; D M Knipe
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

10.  Characterization of varicella-zoster virus gene 21 and 29 proteins in infected cells.

Authors:  Randall J Cohrs; Jeanne Wischer; Carrie Essman; Donald H Gilden
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.